Lantern Pharma Inc. Common Stock LTRN
$2.34
+2.18%
at last close
Market Cap$31.83 million
P/E Ratio—
Div Yield—
Volume149.6K
52-Week Range
$1.11$5.74
Key Stats
- Today's Range
- $2.13 – $2.41
- 50-Day Range
- $2.13 – $4.34
- 52-Week Range
- $1.11 – $5.74
- Volume
- 150K shs
- Average Volume
- 100K shs
- Market Cap
- $31.83 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- -9.89
- Price / Sales
- —
Short Interest
- Short Interest
- 0.21%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- —
- Net Income
- $-18,652,935
- Net Margin
- —
- Return on Equity
- 579.78%
- Debt-to-Equity
- —
About Lantern Pharma Inc. Common Stock
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.
Related Stocks
Compare head-to-head: LTRN vs LLY·LTRN vs JNJ·LTRN vs ABBV·LTRN vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.